FDA Inspection
Octapharma S.A.S.Octapharma S.A.S. – FDA Inspection, Apr 8, 2019
Record Details
This FDA Inspection record concerns Octapharma S.A.S., with an inspection on April 8, 2019, issued by the Office of Inspections and Investigations, covering biologics.
View Company Profile
ID · 8336c1b4-15a5-4df3-94ea-1d6fe1373690
Inspection Facts
- Inspection number
- 1092062
- FDA center
- Biologics
- Outcome
- Form 483 issued
Other FDA inspections of Octapharma S.A.S.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 25, 2026 | Not classified | Office of Inspections and Investigations | Blood and Blood Products |
| November 14, 2025 | Not classified | Office of Inspections and Investigations | |
| December 6, 2022 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 25, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for Octapharma S.A.S.
- FDA Inspection 1337368 - 2026-09-25
- FDA Inspection 1297752 - 2025-11-14
- FDA Inspection 1192276 - 2022-12-06
- FDA Inspection 1053918 - 2018-05-25
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.